Bcl-2 determines susceptibility to induction of lung cancer by oncogenic CRaf

Cancer Research

Volumn 62, Issue 21, 2002, Pages 6297-6303

  Fedorov, Lev M ^a   Tyrsin, Oleg Yu ^a   Papadopoulos, Thomas ^a   Camarero, Guadalupe ^a   Götz, Rudolf ^a   Rapp, Ulf R ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; PROTEIN BCL 2; RAF PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREEDING; CANCER MODEL; CANCER SUSCEPTIBILITY; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; LUNG CANCER; LUNG CARCINOGENESIS; MOUSE; NICK END LABELING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTO ONCOGENE; TRANSGENIC MOUSE; TUMOR RESISTANCE;

ANIMALS; GENES, BCL-2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MICE; MICE, TRANSGENIC; ONCOGENES; PROTO-ONCOGENE PROTEINS C-RAF;

EID: 0036828278     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Kerr, K. M. Pulmonary preinvasive neoplasia. J. Clin. Pathol., 54: 257-271, 2001.
2. Kerkhoff, E., Fedorov, L. M., Siefken, R., Walter. A. O., Papadopoulus, T., and Rapp, U. R. Lung-targeted expression of the c-Raf-1 kinase in transgenic mice exposes a novel oncogenic character of the wild-type protein. Cell Growth Diff., 11: 185-190, 2000.
3. Tuveson, D. A., and Jacks, T. Technologically advanced cancer modeling in mice. Curr. Opin. Genet. Dev., 12: 105-110, 2002.
4. Fisher, G. H., Wellen, S. L., Klimstra, D., Lenczowski, J. M., Tichelaar, J. W., Lizak, M. J., Whitsett, J. A., Koretsky, A., and Varmus, H. E. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev., 15: 3249-3262, 2001.
5. Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., and Tuveson, D. A. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev., 15: 3243-3248, 2001.
6. Johnson, L., Mercer, K., Greenbaum, D., Bronson, R. T., Crowley, D., Tuveson, D. A., and Jacks, T. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature (Lond.), 410: 1111-1116, 2001.
7. Meuwissen, R., Linn, S. C., van, d. V., Mooi, W. J., and Berns, A. Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene. Oncogene, 20, 6551-6558, 2001.
8. Fong, K. M., and Minna, J. D. Molecular biology of lung cancer: clinical implications. Clin. Chest Med., 23: 83-101, 2002.
9. Ranger, A. M., Malynn, B. A., and Korsmeyer, S. J. Mouse models of cell death. Nat. Genet., 28: 113-118, 2001.
10. Rapp, U. R., Huleihel, M., Pawson, A., Minna, J. D., Fanning-Heidecker, G., Cleveland, J. L., Beck, T., Forchhammer, J., and Storm, S. M. Role of raf oncogenes in lung carcinogenesis. Lung Cancer, 4: 162-167, 1988.
11. Daum, G., Eisenmann-Tappe, I., Fries, H-W., Troppmair, J., and Rapp. U. R. The ins and outs of Raf kinases. Trends Biochem. Sci., 19: 474-480, 1994.
12. Marshall, C. J. Cell signalling-Raf gets it together. Nature (Lond.), 383: 127-128, 1996.
13. Kerkhoff, E., and Rapp, U. R. Cell cycle targets of Ras/Raf signalling. Oncogene, 17: 1457-1462, 1998.
14. Hagemann, C., and Rapp, U. R. Isotype-specific functions of Raf kinases. Exp. Cell Res., 253: 34-46, 1999.
15. Wang, H-G., Miyashita, T., Takayama, S., Sato. T., Torigoe, T., Krajewski, S., Tanaka, S., Hovey, I. L., Troppmair, J., Rapp, U. R., and Reed, J. C. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene, 9: 2751-2756, 1994.
16. Wang, H. G., Rapp, U. R., and Reed. J. C. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell, 87: 629-638, 1996.
17. Wang, H. G., Takayama, S., Rapp, U. R., and Reed, J. C. Bcl-2 interacting protein. BAG-1, binds to and activates the kinase Raf-1. Proc. Natl. Acad. Sci. USA, 93: 7063-7068, 1996.
18. Baumann, B., Weber, C. K., Troppmair, J., Whiteside, S., Israel, A., Rapp, U. R., and Wirth, T. Raf induces NF-κB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation. Proc. Natl. Acad. Sci. USA, 97: 4615-4620, 2000.
19. Le Mellay, V., Troppmair, J., Benz, J., and Rapp, U. R. Negative regulation of mitochondrial VDAC channels by C-Raf kinase. BMC Cell Biol., 3: 14, 2002.
20. Wiese, S., Pei, G., Karch, C., Troppmair, J., Holtmann, B., Rapp, U. R., and Sendtner, M. Specific function of B-Raf in mediating survival of embryonic motoneurons and sensory neurons. Nat. Neurosci., 4: 137-142, 2001.
21. Troppmair, J., Cleveland, J. L., Askew, D. S. and Rapp, U. R. v-Raf/v-Myc synergism in abrogation of IL-3 dependence: v-Raf suppresses apoptosis. Curr. Top. Microbiol. Immunol., 182: 453-460, 1992.
22. Zhong, J., Troppmair, J., and Rapp, U. R. Independent control of cell survival by Raf-1 and Bcl-2 at the mitochondria. Oncogene, 20: 4807-4816, 2001.
23. Klinken, S. P., Hartley, J. W., Fredrickson, T. N., Rapp. U. R., and Morse, H. C., III, Susceptibility to raf and mf/myc retroviruses is governed by different genetic loci. J. Virol., 63: 2411-2414, 1989.
24. Michaelidis, T. M., Sendtner, M., Cooper, J. D., Airaksinen, M. S., Holtmann, B., Meyer, M., and Thoenen. H. Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development. Neuron, 17: 75-89, 1996.
25. Domen, J., Gandy, K. L., and Weissman, I. L. Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood. 91: 2272-2282, 1998.
26. Harlow, E., and Lane, D. Using Antibodies. A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press, 1999.
27. Nakayama, K., Negishi, I., Kuida, K., Shinkai, Y., Louie, M. C., Fields, L. E., Lucas, P. J., Stewart, V., Alt, F. W., and Loh, D. Y. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science (Wash. DC), 261: 1584-1588, 1993.
28. Veis, D. J., Sorenson, C. M., Shutter, J. R., and Korsmeyer, S. J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell, 75: 229-240, 1993.
29. Cleveland, J. L., Troppmair, J., Packham, G., Askew, D. S., Lloyd, P., Gonzalez-Garcia, M., Nunez, G., Ihle, J. N., and Rapp, U. R. v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells. Oncogene, 9: 2217-2226. 1994.
30. von Gise, A., Lorenz, P., Wellbrock, C., Hemmings, B., Berberich-Siebelt, F., Rapp, U. R., and Troppmair, J. Apoptosis suppression by Raf-1 and MEK1 requires MEK-and phosphatidylinositol 3-kinase-dependent signals. Mol. Cell Biol., 21: 2324-2336, 2001.
31. Avruch, J., Khokhlatchev, A., Kyriakis, J. M., Luo, Z., Tzivion, G., Vavvas, D., and Zhang. X. F. Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. Recent Prog. Horm. Res., 56: 127-155, 2001.
32. English, J. M., and Cobb, M. H. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol. Sci., 23: 40-45, 2002.
33. Amy, R. W., Bowes, D., Burri. P. H., Haines, J., and Thurlbeck, W. M. Postnatal growth of the mouse lung. J. Anat., 124: 131-151, 1977.
34. Pietenpol, J. A., Papadopoulos, N., Markowitz, S., Willson, J. K., Kinzler, K. W., and Vogelstein, B. Paradoxical inhibition of solid tumor cell growth by bcl2. Cancer Res., 54: 3714-3717, 1994.
35. O'Connor, L., Huang, D. C., O'Reilly, L. A. and Strasser, A. Apoptosis and cell division. Curr. Opin. Cell Biol., 12: 257-263, 2000.
36. Kroemer, G., and Reed, J. C. Mitochondrial control of cell death. Nat. Med., 6: 513-519, 2000.
37. Shimizu, S., Konishi, A., Kodama, T., and Tsujimoto, Y. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death, Proc. Natl. Acad. Sci. USA, 97: 3100-3105, 2000.
38. Meredith, M. J., Cusick, C. L., Soltaninassab, S., Sekhar, K. S., Lu, S., and Freeman, M. L. Expression of Bcl-2 increases intracellular glutathione by inhibiting methionine-dependent GSH efflux. Biochem. Biophys. Res. Commun., 248: 458-463, 1998.
39. Ilyas, M., Hao, X. P., Wilkinson, K., Tomlinson, I. P., Abbasi, A. M., Forbes, A., Bodmer, W. F., and Talbot, I. C. Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer. Gut, 43: 383-387, 1998.
40. Bold, R. J., Virudachalam, S., and McConkey, D. J. BCL2 expression correlates with metastatic potential in pancreatic cancer cell lines. Cancer (Phila.), 92: 1122-1129, 2001.